Published in Law and Health Weekly, November 18th, 2006
Net income for 2006 was reduced by $13 million of pretax expenses, or $0.04 per share, associated with stock-based compensation recorded in accordance with SFAS 123R.
Third quarter revenues from continuing operations grew 16.3% over the prior year level to $1.6 billion. The acquisition of LabOne, which was completed on November 1, 2005, increased revenues by 9.4%, and the acquisition of Focus Diagnostics, which was completed on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.